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Abstract 
Background: Cancer has to become the scariest disease and tends to reduce the quality of life of the patient. 
Therefore, it is not only a medical treatment that needs to be conducted but also a psychological treatment. 
AIM: to analyse the relationship between affective psychopathology and the quality of life of breast cancer 
patients who are receiving radiotherapy treatment.  
METHODS: This research was a correlative analytical study with a cross-sectional approach using the Hospital 
Anxiety and Depression Scale (HADS) instrument to assess psychopathological features and the European 
Organization for Research and Treatment of Cancer Quality of Life Questionnaire-C30 (EORTC QLQ-C30) to 
determine the quality of life. This research was conducted in March 2016-July 2016 at Vina Estetika Cancer 
Center Hospital, Medan, Indonesia. As many as 47 subjects were divided into two criteria; Inclusion criteria, 
participants with breast cancer who were undergoing radiotherapy, aged over 18 years, with HADS score ≥ 17, 
and the exclusion criteria, were patients suffering from chronic psychiatry diseases. 
RESULTS: Affective psychopathology was indicated to result in a significant negative correlation with the quality 
of life of breast cancer patients which whom were treated with radiotherapy with p = 0.035 and r = -0.267. This 
suggests that with a higher HADS, a decrease in quality of life will occur. 
CONCLUSIONS: Affective psychopathological comorbidities have a great influence on the quality of life of 
patients who are undergoing radiotherapy. Thus, cancer management must include screening for 
psychopathological morbidity. Moreover, psychological rehabilitation must also be provided along with the cancer 
treatment. 
 
 
 
 
 
 
Introduction 
 
Cancer, considered as a serious and chronic 
disease has been described to eliminate hope and 
certainty of the patients to be cured and reminded 
people of painful deaths, guilty, anxiety, and caused 
panic and confusion [1]. The first reaction to a disease 
that a person experience is shocked and distrusted. In 
the second phase, the patient's reaction becomes 
wider. The basic reaction in this period is anxiety. The 
third phase is the period in which the patient can 
accept reality. This is a period in which patients learn 
to live with their illness. If emotions and behavioural 
reactions exceed the expected limits, this can turn into 
depression. Cancer is one of the leading causes of 
death worldwide. In 2012, around 8.2 million deaths 
were caused by cancer. Lung, liver, colorectal and 
breast cancer are the biggest contributors of cancer 
deaths every year [2]. 
A research conducted by Hassan et al. 
discovered the prevalence of depression in breast 
cancer patients was 22.0%, and anxiety was 31.7%. 
Moreover, So et al., in Hong Kong, revealed that 
anxiety and depression have a detrimental effect on 
the whole and other scales on the quality of life of 
breast cancer patients undergoing adjuvant therapy 
such as radiotherapy [3], [4], [5]. 
Depression and anxiety are very important 
psychopathological comorbidities in cancer patients 
[6]. Hospital Anxiety and Depression Scale (HADS) is 
a self-assessment scale developed for use in medical 
purposes. It was firstly developed by Zigmond and 
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Snaith which aimed to provide clinicians with 
acceptable, trustworthy, valid and easy tools to 
identify and quantify anxiety and depression. The term 
"Hospital" in HADS is intended to not only valid in the 
arrangement, but also many studies have been 
carried out throughout the world, and it has been 
confirmed that it is also valid when used in the 
community and medical practice services [7], [8], [9], 
[10]. 
According to research conducted by Ozalp et 
al.stated that the total score of HADS with a cut-off 
value of ≥ 17 was optimal in identifying cases of major 
depression. This cut-off value had a sensitivity of 0.70 
and a specificity of 0.80. HADS is also recommended 
as a screening tool for people living with breast cancer 
[11]. 
By knowing the correlation between effective 
psychopathologists on the quality of life of breast 
cancer patients who are undergoing radiotherapy, the 
input to health workers to detect early and anticipate 
when needed management psychological sequelae in 
cancer patients and management of psychological 
aspects of palliative and end of life care for the breast 
cancer patients can be obtained. 
To sum up, this research aimed to assess the 
correlation between effective psychopathology and 
quality of life in breast cancer patients who are 
undergoing radiotherapy at Vina Cancer Center 
Medan Hospital, which in turn is expected to provide 
information to clinicians and breast cancer patients.  
 
 
Methods 
 
This research took place at Vina Estetika 
Cancer Center Hospital, located in Medan, Indonesia. 
The research was conducted from March to August 
2016 with a total sample of 47 people collected using 
the consecutive sampling method [12]. 
Inclusion criteria: Breast cancer patients who 
were undergoing radiotherapy, aged over 18 years, 
with total HADS number ≥ 17. 
Exclusion Criteria: Patients who were 
suffering from other psychiatric illnesses before being 
diagnosed with breast cancer and were not suffering 
from other chronic diseases, such as cardiovascular 
and lung disease. 
Consent and explanation were given to the 
breast cancer patients who were treated with 
radiotherapy that meets the inclusion and exclusion 
criteria. Furthermore, patients were interviewed with a 
structured interview and provided with the opportunity 
to fill out the HADS and EORTC QLQ-C30 
questionnaires at once, which only took about 5-10 
minutes to complete the questionnaire [13]. 
HADS consists of 14 statements which are 
divided into 2 subscales, namely to assess anxiety (7 
statements) and depression (7 statements), which the 
patients classify each statement in 4 value scales, 
from 0 (not at all) to 3 (very often). Higher values 
indicate problems. Patient answers were summed up 
separately, which is an assessment of anxiety and 
assessment for depression, with a minimum and a 
maximum number of 0 and 21 for each scale. The 
recommended cut points were: more than 16 states 
severe cases, the cutoff point 11-15 is a moderate 
case, the cutoff 8-10 states a mild case, and less than 
7 is not a case of anxiety or depression [3], [9], [10], 
[14], [15]. 
Research and Treatment of Cancer Quality of 
Life Questionnaire-C30 (EORTC QLQ-C30) is an 
integrated system to assess the quality of life of 
cancer patients who participated in clinical trials. 
EORTC QLQ-C30 combines various scales such as 
functional, symptom, global health status and the 
financial impact caused by the disease [16], [17], [18]. 
 
Statistical analysis 
Sapphiro-Wilk test was performed to 
determine the normality distribution of the data. 
Furthermore, Pearson test was conducted for 
analysis. Both of these tests were carried out via 
SPSS 22 program. 
 
 
Results 
 
Characteristics of Samples and Basic Data 
for Test Variables 
The characteristics of this research subject 
are displayed in Table 1. From the table, it can be 
seen that the average age of the subject was 50.60 
years with a standard deviation of 8.831 years, and a 
minimum age of 33 years and a maximum of 69 
years. 
Table 1: The demographic characteristic of the research 
subject 
Variable Mean/f SD/% 
Age 50.60 8.831 
Education Level:   
Elementary 6 12.8 
Junior High School 8 17.0 
Senior High School 20 42.6 
Undergraduate 12 25.5 
Postgraduate 1 2.1 
Marital Status   
Single 1 2.1 
Married 46 97.9 
Occupational Status   
Work 27 57.4 
Jobless 20 42.6 
Score *21.19 1.930 
Score **44.673 8.7611 
Score ***53.860 8.5166 
Score ****21.19 1.930 
*HADS Score; **SS/I; ***FS; ****GHS/QoL. 
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The most education level recorded is in senior 
high school with 20 people (42.6%). The most 
common marital status is married to many as 46 
people (97.9%). And the most occupational status is 
working for 27 people (57.4%). The overall HADS 
score was found to be a minimum of 19 and a 
maximum of 27 with 21.19 and a standard deviation of 
1.930. Based on the results of the normality test, 
using the Saphiro-Wilk test, the p-value = 0.001 (p < 
0.05), so it can be concluded that the data were not 
normally distributed. Therefore, the data were 
transformed using the mathematical formula 1/Log 
(Log
(data)
) and tested for the normality again. Finally, it 
was proven to be normally distributed with p = 0.068 
(p > 0.05). 
The overall subject SS/I score was a 
minimum of 17.9 and a maximum of 64.1 with a mean 
of 44.673 and standard deviation of 8.7611. These 
data were normally distributed, referred to the results 
of Saphiro-Wilk test with p = 0.141 (p > 0.05). The 
overall subject FS score was a minimum of 33.4 and a 
maximum of 80 with a mean of 53.860 and standard 
deviation of 8.5166. Based on the results of the data 
normality test using Saphiro-Wilk, the data were 
normally distributed with p = 0.208 (p > 0.05). 
The overall GHS/QoL score was a minimum 
of 16.6 and a maximum of 75 with a mean of 21.19 
and a standard deviation of 1.930. From the results of 
the normality test using Saphiro-Wilk, it was found that 
the value of p = 0.141 (p > 0.05), so it can be 
concluded that the data is normally distributed. 
 
The Correlation between hands and SS / I 
Based on Table 2, it can be seen that the 
correlation between the HADS score and the 
Scales/Items (SS/I) Symptom score was obtained with 
p < 0.005 which showed that the correlation between 
the HADS score and the Symptom scales (SS) score 
is significant. The Pearson correlation value of 0.400 
indicates a positive correlation with moderate 
correlation strength (r = 0.4- < 0.6). 
Table 2: The correlation between HADS and SS/I 
Variable ẋ SD r p 
HADS Score 21.19 1.930 0.00 *0.003 
SS/I Score 44.673 8.7611   
*Pearson Correlation Test. 
 
 
The Correlation between hands and FS 
Table 3 reveals that the correlation between 
HADS scores and Functional scales (FS) scores 
resulted in p-value > 0.05 which indicates that the 
correlation between HADS scores and Functional 
scales (FS) scores is not significant. The Pearson 
correlation value of -0.155 showed a negative 
correlation with a very weak correlation strength (r = 
0.0- < 0.2). 
Table 3: The correlation between HADS and FS 
Variable ẋ SD r p 
HADS Score 21.19 1.930 -0.155 *0.148 
FS Score 53.860 8.5166   
*Pearson Correlation Test. 
 
 
HADS correlation with GHS/QoL 
Based on Table 4, it can be seen that the 
correlation between the HADS score and the Global 
health status (QoL) score is obtained with the value of 
p < 0.05 which indicates a significant correlation 
between the HADS score and the Global health status 
(QoL) score. The Pearson correlation value of -0.267 
showed a negative correlation with the strength of a 
weak correlation (r = 0.2 < -0.4) in a negative 
direction. 
Table 4: The correlation between HADS and Global Health 
Status/QoL 
Variable ẋ SD R p 
Skor HADS 21.19 1.930 -0.267 *0.035 
Skor GHS/QoL 40.598 13.3041   
*Pearson Correlation Test. 
 
 
 
Discussion 
 
This research is a correlative analytic study 
with a cross-sectional approach which is describing 
and analysing a situation at a certain time. In this 
case, the analysis conducted was a correlation 
between effective psychopathology and quality of life 
in breast cancer patients who were undergoing 
radiotherapy using the Hospital Anxiety and 
Depression Scales (HADS) to assess the affective 
psychopathology and the European Organization for 
Research and Treatment of Cancer Quality of Life 
Questionnaire-C30 (EORTC QLQ-C30) to assess 
quality of life. The research sample was obtained by 
nonprobability consecutive sampling method [14]. 
Based on the result of the research, the 
demographic characteristics of the study subjects 
were found by previous research. Based on the 
demographic characteristics of cancer patients 
observed, the average age of patients with cancer 
was 53.04 ± 13.8, for the most common marital status 
is married as many as 280 people (84.8%), while for 
education is different from this study where the most 
common is primary education, as many as 143 people 
(43.3%) [1]. 
The study conducted by Sharma and Zhang 
found the mean age of 51.92 (SD = 10.178) years, for 
the highest marital status was married as much as 
85% [19]. Likewise, with the study conducted by 
Winnie, the demographic characteristics were found to 
have the average age of 52.75 (SD = 11.73) years, 
and the most marital status was married as much as 
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65.5%, but from a slightly different job status which 
was jobless as much as 74.7% [4]. 
This research found a significant correlation 
between the HADS score and the Scales/Items (SS/I) 
Symptom. The Pearson correlation value also shows 
a positive correlation with moderate correlation 
strength. This can be concluded that the higher the 
HADS, the higher the symptom scale in patients. This 
shows the understanding between the HADS 
questionnaire and the symptom scale on EORTC 
QLQ-30. According to Fatiregun et al., which the 
research was aimed to examine the relationship 
between psychopathology and symptom scale, the 
mean value of participants showed that those who 
suffered from psychopathology had a higher symptom 
scale than those who were not having 
psychopathology. The significant differences were 
found in the fatigue domain, pain, insomnia, loss of 
appetite, diarrhoea, and financial problems [20]. 
However, the correlation between HADS 
scores and Functional scales (FS) scores was not 
significant. Moreover, Pearson correlation value 
showed a negative correlation with very weak 
correlation strength. This shows that the higher the 
HADS, it results in a decrease in the function scale. 
This is likely due to the minimum number of research 
subjects. This is by the research result from Sharma 
et al., has reported. It was discovered that anxiety and 
depression are not only limiting the treatment time but 
also extending the success of management. 
Depression and anxiety are not only affecting the 
quality of life but also affecting the adherence to 
anticancer management, which is associated with 
longer hospitalisations and can lead to a poor 
prognosis. 
Moreover, the limitations of daily activities, 
disability, poor prognosis, exhausting side effects, and 
social isolation can result in anxiety. This will interfere 
with the ability to maintain everyday life or self-care, 
the coping process leads to negative perceptions 
about self, life and the future, despair, and finally, the 
patient shows depressive symptoms. Greater 
psychological morbidity in cancer patients tends to 
accelerate disease progression and shorter survival 
[19]. Similarly, Fatiregun et al., also found that 
psychopathologists showed a lower mean value to the 
function scale, which includes physical, emotional, 
social and cognitive functions [20]. 
In the other hand, a significant correlation 
between the HADS score and the Global health status 
(QoL) score was obtained. Also, the Pearson 
correlation value showed a negative correlation with 
the strength of the weak correlation. It shows that the 
higher the HADS, it will lead to a decrease in quality of 
life. This is by research conducted by Hutter, showed 
a significant correlation between HADS and the 
quality of life of breast cancer patients with a value of r 
= -0.207 [3]. Frick also discovered that effective 
psychopathology was significantly correlated with a 
decrease in quality of life in cancer patients [6]. 
To date, this research is the first study 
conducted in Indonesia to use HADS with a total cut-
off score of ≥ 17, which according to a study 
conducted by Ozalp in Turkey, total HADS score with 
a cut-off value of ≥ 17 was very optimal in identifying 
cases of affective psychopathology such as major 
depression. And this cut-off value has a sensitivity of 
0.70 and a specificity of 0.80. HADS has also been 
recommended as a screening tool for affective 
psychopathology for breast cancer patients [11]. 
In conclusion, this research indicated a 
significant correlation between affective 
psychopathologists on the quality of life of breast 
cancer patients undergoing radiotherapy at Vina 
Cancer Center Medan Hospital with p = 0.035 (p < 
0.05) and r = -0.267 with negative direction. It 
indicates that the higher the HADS, it will lead to a 
decrease in quality of life. Moreover, the screening 
process must be considered for the possibility of 
effective psychopathological comorbidity which is very 
important since the high risk of depression and 
anxiety in cancer patients, to improve the quality of life 
of patients. Finally, good cooperation is needed 
between the oncology specialists and psychiatrist to 
improve their quality of life. 
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